Navigation Links
Clarient Acquires Applied Genomics, Inc.
Date:12/21/2009

mon stock issued to the former AGI stockholders at closing and up to 3.2 million additional shares of Clarient common stock issuable to the former AGI stockholders contingent upon the satisfaction of certain clinical, commercial and revenue milestones set forth in the merger agreement. The shares issued at closing will be reduced by 440,000 shares that will be placed into an escrow account to cover future indemnity claims.

"AGI's lung cancer pipeline fulfills an important strategic need for Clarient. Having a test that provides us access to the primary lung tumor block much earlier in the diagnostic process will allow Clarient to provide pathologists with critical information at the early stages of therapy decision. It also strengthens our position to gain a greater share of the rapidly increasing EGFR (epidermal growth factor receptor) mutation testing market. The development of lung cancer diagnostics has been slow relative to other cancers; however, we now have a powerful foundation upon which to build a market-leading lung cancer franchise," continued Andrews.

In addition to Pulmotype, AGI has a pipeline of cancer diagnostic, prognostic and theranostic tests at various stages of validation and planned commercialization. Theranostics are a class of tests that assist in the selection of therapies by determining an individual patient's reaction to a specific therapeutic drug. The portfolio of tests includes a theranostic that may predict the response of a patient's cancer to taxane therapy across a variety of cancers, including lung, breast and ovarian. The taxane class of chemotherapeutic agents is widely used, and understanding a patient's propensity to respond before administering this powerful drug will provide clinicians a much needed tool to aid in personalizing cancer treatment. AGI also has a breast cancer panel with proprietary markers that could be included in a future version of Clarient's Insight® Dx, as well as separate
'/>"/>

SOURCE Clarient, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Clarient to Present at Upcoming Healthcare Investor Conferences in New York City
2. Clarient, BioView Initiate Alliance to Finalize Development and Commercialize Non-Invasive Molecular Diagnostic Test for Early Detection of Lung Cancer
3. Clarient Announces CFO Transition Plan
4. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
5. Image Solutions, Inc. Acquires Zurich Biostatistics, Inc.
6. U.S. Preventive Medicine Acquires Specialty Disease Management
7. MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
8. Nastech Reacquires Teriparatide (Parathyroid Hormone; PTH1-34) Nasal Spray from Procter & Gamble
9. Prescient Medical, Inc. Acquires New Technology to Detect Inflammation in Coronary Blood Vessels
10. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim
11. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim and Manufacturing Facility From PLIVA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... , June 1, 2015  bioMérieux, a world leader ... has been invited to join the White House Forum ... in the U.S. as a means to address antibiotic ... gather tomorrow, June 2, 2015, to discuss the possible ... to slow the emergence of antibiotic-resistant bacteria, and prevent ...
(Date:6/1/2015)... The Middle Eastern MRI systems market is fast ... in all domains of medicine like cardiology, neurology and orthopedics. ... better precision and is as safer tool as it does ... based on equipment into Open system, closed system and straight ... market demand as it is preferred over that currently common ...
(Date:6/1/2015)... , June 1, 2015 ... segment will drive growth , says   GBI ... Lung Cancer (NSCLC) treatment market will be driven primarily by ... squamous cell treatment settings, which either replace or combine with ... Research - Non-Small Cell Lung Cancer Market to 2020 ...
Breaking Medicine Technology:bioMerieux Honored to Participate in the White House Forum on Antibiotic Stewardship 2bioMerieux Honored to Participate in the White House Forum on Antibiotic Stewardship 3Middle East MRI Market - Growth, Trends And Forecasts (2014 - 2019) 2Middle East MRI Market - Growth, Trends And Forecasts (2014 - 2019) 3New Therapies to Enhance Increasingly Competitive Non-Small Cell Lung Cancer Treatment Market 2New Therapies to Enhance Increasingly Competitive Non-Small Cell Lung Cancer Treatment Market 3
... 2012  Avaxia Biologics, Inc., a privately-held biotechnology company ... the gastrointestinal tract, announced today that the company ... Using Anti-TNF Antibodies for Treating Radiation Damage to ... broad coverage for using topically administered anti-TNF antibodies ...
... announced today results from a Phase II study ... the Respimat ® Inhaler in adolescents with ... at the 2012 Annual Meeting of the American ... a comprehensive confirmatory Phase III trial program named ...
Cached Medicine Technology:Avaxia Biologics is Awarded U.S. Patent for Method to Treat Radiation Damage to the Digestive Tract and Mucositis Caused by Radiation 2Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma 2Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma 3Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma 4
(Date:6/2/2015)... Join us for a new event in Westwood, New ... Martin , who overcame her brain aneurysm during the summer ... raising awareness and funds for brain aneurysm research. , ... there will be one less case of someone suffering from ... join the 1st Anniversary Awareness Walk in Honor of ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 “We want men ... ultraviolet (UV) sun rays”, states Marta Phillips, owner of SunGrubbies.com, ... men’s sun hats and sun accessories that work well for ... not immediately evident. Sometimes sun damage can take up to ... neck are prime areas for skin cancer to occur. ...
(Date:6/1/2015)... The National Association of Professional Women ... 2015-2016 inductee into the NAPW VIP Professional Woman of ... distinction for leadership in academics. With more than 700,000 ... the nation’s leading networking organization exclusively for professional women. ... distinction,” said NAPW President Star Jones. “She is a ...
(Date:6/1/2015)... NY (PRWEB) June 02, 2015 ... Selma Tansey as a 2015-2016 inductee into ... recognized with this prestigious distinction for leadership in mental ... for professional women, boasting more than 700,000 members and ... present Selma with this important honor," said NAPW President ...
(Date:6/1/2015)... 2015 Ticket Down announces that the Golden ... Conference Finals and now will face the Cleveland Cavaliers in ... at the Oracle Arena in Oakland and the Quicken Loans ... Basketball Association season, the Golden State Warriors were the elite ... that learned from their playoff failures from the year and ...
Breaking Medicine News(10 mins):Health News:New Awareness Raising Event in Westwood, NJ to Benefit Renowned Brain Aneurysm Foundation 2Health News:It is Time to Show Father Who Knows Best, Says SunGrubbies.com, a Leading Online Sun Protection Retailer 2Health News:National Association of Professional Women Inducts Marcia Ditmyer, Vice President of Academy for Academic Leadership, Into its VIP Professional Woman of the Year Circle 2Health News:NAPW Inducts Selma Tansey, Executive Director of Washington Communities Human Services, Into its VIP Professional Woman of the Year Circle 2Health News:Warriors NBA Finals Tickets: 2015 NBA Finals Feature the Golden State Warriors vs. the Cleveland Cavaliers 2Health News:Warriors NBA Finals Tickets: 2015 NBA Finals Feature the Golden State Warriors vs. the Cleveland Cavaliers 3
... ... ... ... ...
... colon cancer are at greater risk for death or recurrent ... range, according to a report in Clinical Cancer Research, ... "Obesity has long been established as a risk ... shows that obesity predicts a poorer prognosis after the cancer ...
... to lung cancer face a greatly increased risk for ... cigarette smoke, a study team that includes researchers from ... members who carry this genetic variant, the risk of ... smokers, the researchers say, adding that even non-smokers who ...
... in domestic violence consistently overestimated how common such behavior is, ... in abusing their partner in the previous 90 days, according ... men overestimated by two to three times the actual rates ... to rape, according Clayton Neighbors, lead author of a paper ...
... finds progress in reducing cancer death rates is evident whether ... study appears in the open access journal PLos ONE, ... 1990 results mostly from reductions in tobacco use, increased screening ... improvements in treatment for specific cancers. Temporal trends in ...
... ... Research in inflammatory bowel diseases (IBD) is ... and often debilitating digestive diseases impacting 1.4 million Americans—are diagnosed ... , Crohn’s and colitis patients, families, and caregivers can tune ...
Cached Medicine News:Health News:GoodTherapy.org and PsychCentral.com Partner to Help Therapy Seekers Find a Therapist 2Health News:GoodTherapy.org and PsychCentral.com Partner to Help Therapy Seekers Find a Therapist 3Health News:GoodTherapy.org and PsychCentral.com Partner to Help Therapy Seekers Find a Therapist 4Health News:GoodTherapy.org and PsychCentral.com Partner to Help Therapy Seekers Find a Therapist 5Health News:GoodTherapy.org and PsychCentral.com Partner to Help Therapy Seekers Find a Therapist 6Health News:Obesity linked to poor colon cancer prognosis 2Health News:Genetic variant greatly increases lung cancer risk for light smokers 2Health News:Male batterers consistently overestimate rates of violence toward partners 2Health News:Study finds cancer mortality has declined since initiation of 'war on cancer' 2Health News:National Event Addresses Breakthroughs in Crohn's & Colitis Research: National Expert & Researcher Answers Key Questions on Interactive Webcast/Teleconference 2Health News:National Event Addresses Breakthroughs in Crohn's & Colitis Research: National Expert & Researcher Answers Key Questions on Interactive Webcast/Teleconference 3Health News:National Event Addresses Breakthroughs in Crohn's & Colitis Research: National Expert & Researcher Answers Key Questions on Interactive Webcast/Teleconference 4
... NsD Nucleic Sample Detection Platform provides fully ... The new platform for molecular pathology ... (CE), with software features that deliver a ... Vidiera NsD has the capacity to run ...
Invacare 5 Oxygen Concentrator, 230 VAC - Intl....
... INVACARE CHECK 02 PLUS CONCENTRATOR ANALYZER Now ... all the operating parameters necessary for performing ... Plus ™, an efficient and cost-effective analyzer ... oxygen concentration (%), flow rate (L-min), and ...
... 10 concentrator. The Platinum 10 delivers the ... come to expect from the Platinum line ... to liquid systems. The Platinum 10 is ... high flow patients, and has less than ...
Medicine Products: